Health technology assessment (HTA) and economic evaluation have traditionally focused on comparing individual drugs through head-to-head randomized controlled trials and cost-effectiveness models. ...
No takes yet. Share an insight, caveat, or question.
François et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: